Fundraising FoxNovo Holdings — 2022 Investments
10 investments dated 2022 · listed companies and verified rows first · show all
Biomason uses biotechnology to grow biocement, producing concrete and tile products by using bacteria to bind natural materials as an alternative to Portland cement, aimed at concrete producers and the construction industry.
BiotechClimate TechConstruction TechNew MaterialsResearch Triangle Park, US
Ginger K. Dosier(Executive Officer, Director)inMichael F. Noel(Director)John M. Dosier(Executive Officer)Camilo Restrepo(CEO and President)in
Board seatAnders Bendsen Spohr· per SEC Form D
Co-investorsCarbonCelesta Capital
Elektrofi is a biotech company developing an ultra-high concentration microparticle formulation platform that enables subcutaneous delivery of biologic medicines such as monoclonal antibodies.
BiotechDeep TechHealthtechMedical DevicesBoston, US
Chase Coffman(Chief Executive Officer & Co-founder)inSam Huang(Director)Jason Norris(Co-founder)Charles L. Cooney(Director)Andrew Goldberg(Director)Constatine Chinoporos(Director)
Co-investorsBiotechnology Value FundCatalio Capital Management, LPCharlotte Angel FundGeneral CatalystRA CapitalSR One Capital Management+1 more
.png)
MedGenome provides genetic and molecular diagnostic testing across areas including reproductive care, rare hereditary conditions, oncology, and infectious diseases, and operates a CAP-accredited multiomics laboratory with high-throughput sequencing and a proprietary analytics platform.
BiotechDigital HealthHealthtechMedical DevicesBangalore, IN
Co-investorsSofinaATEL VenturesPeak XV PartnersLeapFrog Investments
MycoWorks produces Reishi, a premium biomaterial made from Fine Mycelium, used as a sustainable leather alternative in furniture, design, and automotive products.
BiotechCircular EconomyNew MaterialsEmeryville, US
Philip Ross(Founder)inMichael Lindheim(Executive Officer)Matthew Scullin(Executive Officer, Director)inEddie Pavlu(Founder)Phil Ross(Founder)Sophia Wang(Founder)
Board seatAnders Bendsen Spohr· per SEC Form D
Co-investorsATEL VenturesDCVC (Data Collective)GaingelsHemisphere Ventures LLCSOSVValor Equity Partners+9 more
__Twitter.png)
Biosyntia is a Copenhagen-based industrial biotech company that uses strain engineering and fermentation to produce sustainable, bio-based active ingredients like vitamin B7, replacing petrochemical-derived alternatives for cosmetics and nutrition markets.
Copenhagen, DK
Hans Genee(Founder)Morten Sommer(Founder)
Co-investorsEuropean Circular Bioeconomy FundSofinnova Partners
Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.
BiotechDigital HealthHealthtechMedical DevicesMunich, DE
Rafiq Hasan(CEO and Managing Director)inMuhammad Ali Memon(Chief Medical Officer)in
Co-investorsBioGeneration VenturesCambridge Innovation CapitalGimvHadean VenturesSeroba Life SciencesBGV+2 more
Inspirna is a clinical-stage biopharmaceutical company developing novel cancer drugs that target previously undruggable drivers of metastasis using its proprietary miRNA-DRIVEr platform.
BiotechHealthtechMedical DevicesNew York, US
Sohail Tavazoie(Co-Founder & Chair of Scientific Advisory Board)Masoud Tavazoie(Co-Founder & Advisor)in
Co-investorsSofinnova PartnersVivo CapitalSands Capital VenturesStart Capital
Metagenomi is a genetic medicines company developing therapies based on gene editing technologies to treat patients with serious diseases.
BiotechDeep TechHealthtechMedical DevicesBerkeley, US
Brian Thomas(Founder)inBrian Thomas Jillian Banfield(Founder)Jill Banfield(Founder)Jian Irish(President and CEO)
BoardAndrew Farquharson(Director)inJak Knowles(Director)
Co-investorsCatalio Capital Management, LPRA CapitalSozo VenturesAgent CapitalFrazier Life SciencesHumboldt+5 more
Qure.ai builds deep learning and AI software to detect and manage diseases such as lung cancer, tuberculosis, pediatric TB, and stroke, with several FDA-cleared solutions.
AI & Machine LearningDigital HealthHealthtechMedical DevicesNew York, US
Prashant Warier(Founder)inPooja Rao(Founder)
Co-investorsCrane Venture PartnersHealthQuadLightspeed India PartnersLightspeed Venture PartnersMerck Global Health Innovation FundMSD Global Health Innovation Fund+6 more
Rondo Therapeutics is an immuno-oncology biopharmaceutical company developing bispecific/multispecific antibody therapeutics designed for tumor-selective targeting to treat solid tumors while sparing healthy tissue.
BiotechHealthtech
Shelley Force Aldred(Co-Founder & Chief Executive Officer)inNathan Trinklein(Co-Founder, President & CSO)inKatherine(Chief Development Officer)Thomas(Chief Medical Officer)
Co-investorsCanaan PartnersDementia Discovery FundRed Tree VentureSV Health InvestorsJohnson & Johnson Innovation – JJDC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.